Calabdion: A new agent to revert the effects of steroid or benzylisoquinoline neuromuscular blocking agents

Authors

  • Idoris Cordero Escobar

Downloads

Download data is not yet available.

References

Grosse-Sundrup M, Hoffmann U, Elamine L, Zhang B, Eikermann-Haerter K, Ayata C, Isaacs L, Eikermann M. New Broad Spectrum Reversal Agent for Benzylisoquinoline and Steroidal Neuromuscular Blocking Agents.

Hoffmann U, Grosse-Sundrup M, Eikermann-Haerter K, Zaremba S, Ayata C, Zhang B, Ma D, Isaacs L, Eikermann M. Calabadion: A New Agent to Reverse the Effects of Benzylisoquinoline and steroidal neuromuscular blocking agents. Anesthesiology. 2013 Aug;119(2):317-25. doi: 10.1097/ALN.0b013e3182910213.

Lien CA. Calabadion. Anesthesiology. 2010;112:16-8.

Downloads

Published

2017-05-07

How to Cite

1.
Cordero Escobar I. Calabdion: A new agent to revert the effects of steroid or benzylisoquinoline neuromuscular blocking agents. Rev Cub Anest Rean [Internet]. 2017 May 7 [cited 2024 Dec. 23];16(2). Available from: https://revanestesia.sld.cu/index.php/anestRean/article/view/145

Issue

Vol. 16 No. 2 (2017): may - august

Section

Editorials

License

Those authors who have publications with this journal accept the following terms:

      • They will retain their copyright and guarantee the journal the right of the first publication of their work.
      • All the content of the journal is under a license https://creativecommons.org/licenses/by-nc/4.0/deed.es_ES
      • It is recommended to the author to insert their articles in recognized preprints serves and introduce their database in server crated to this end.

 

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 11 > >>